Prednisone Decreases Opioid Use in Adults Undergoing Benign Oropharyngeal Surgery
Otolaryngology–Head and Neck Surgery · 2024
DOI: 10.1002/ohn.515 ↗At a glance
Journal article in Otolaryngology–Head and Neck Surgery, 2024. Written by Joann M Butkus and 9 co-authors. Institution: Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Analgesics, Opioid, Opioid-Related Disorders. Cited 4 times so far (Crossref); 59 references.
Abstract (original language)
Objective
This study sought to analyze the efficacy and safety of postoperative prednisone to reduce reliance on opioids in adult benign oropharyngeal surgery. Study Design Prospective cohort study.
Setting
Single tertiary‐care facility.
Methods
Patients undergoing tonsillectomy (T), tonsillectomy and adenoidectomy (T&A), and/or modified uvulopalatopharyngoplasty (UPPP) from December 2020 to January 2023 received the standard of care postoperative management. A prednisone taper was dependent on surgeon preference. Cohorts were based on the prescription of postoperative steroids. Patients completed a survey to assess opioid usage, pain scores, and steroid compliance.
Results
Seventy‐two patients were included. The nonsteroid cohort (N = 29) received an average of 467 ± 94.1 morphine milligram equivalents (MME), and the steroid cohort (N = 43) received an average of 285 ± 128 MME ( P < 0.001). The nonsteroid cohort consumed 1.62 times more opioids than the steroid cohort ( P < 0.002). There were no significant differences in complication or refill rates between treatment groups. There were no significant differences in pain scores on the day of surgery or postoperative days 1, 5, or 10 ( P = 0.34, P = 0.66, P = 0.62, and P = 0.22, respectively). Patients undergoing T&A ( p = 0.019) or who had current psychiatric medication use ( P < 0.006) consumed significantly more opioids. Patients who received a total opioid prescription of >300 MME (40 5‐mL doses of 5 mg/5 mL liquid oxycodone) consumed 2.27 times more postoperative opioids than patients with opioid prescriptions ≤300 MME ( P < 0.001).
Conclusion
Patients who did not receive steroids consumed 1.62 times more postoperative opioids compared to those who completed a steroid taper. Corticosteroid use was not associated with changes in pain scores, refill rates, or complication rates and may be considered in a multimodal approach to pain management in adults undergoing benign oropharyngeal surgery, although further study is warranted.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Otolaryngology-Head and Neck Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
- Department of Biostatistics, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.
ORCID profiles: Joann M Butkus, Emily S Sagalow, Samuel Alfonsi, Brian McGettigan, Maurits Boon
Cite
APA
Butkus, J. M., Sagalow, E. S., Alfonsi, S., Riordan, J., Zhan, T., McGettigan, B., Fisher, K., Rosen, D., Boon, M., & Huntley, C. (2024). Prednisone Decreases Opioid Use in Adults Undergoing Benign Oropharyngeal Surgery. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.515
Vancouver
Butkus JM, Sagalow ES, Alfonsi S, Riordan J, Zhan T, McGettigan B, et al. Prednisone Decreases Opioid Use in Adults Undergoing Benign Oropharyngeal Surgery. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.515
BibTeX
@article{Butkus2024,
author = {Butkus, Joann M and Sagalow, Emily S and Alfonsi, Samuel and Riordan, Jacob and Zhan, Tingting and McGettigan, Brian and Fisher, Kyle and Rosen, David and Boon, Maurits and Huntley, Colin},
title = {Prednisone Decreases Opioid Use in Adults Undergoing Benign Oropharyngeal Surgery},
journal = {Otolaryngology–Head and Neck Surgery},
year = {2024},
doi = {10.1002/ohn.515}
}
EUVIMED